RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023
26 Ottobre 2023 - 10:05PM
(NASDAQ: RXST) – RxSight, Inc., an ophthalmic
medical device company dedicated to providing high-quality
customized vision to patients following cataract surgery, today
announced that it will report financial results for the third
quarter 2023 after the market close on Thursday, November 9, 2023.
The company’s management will discuss the results during a
conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m.
Eastern Time.
Participants may register for the call here and listen through a
live and archived webcast of the event available for one year at
https://investors.rxsight.com/. While not required, it is
recommended that participants join ten minutes prior to the event
start time to ensure the necessary audio applications are
downloaded and installed. Instructions are provided (including a
dial-in option).
About RxSight, Inc.RxSight, Inc. is an
ophthalmic medical device company dedicated to providing
high-quality customized vision to patients following cataract
surgery. The RxSight® Light Adjustable Lens system, comprised of
the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery
Device (LDD™) and accessories, is the first and only commercially
available intraocular lens (IOL) technology that can be adjusted
after surgery, enabling doctors to customize and deliver
high-quality vision to patients after cataract surgery. Additional
information about RxSight can be found at www.rxsight.com.
Company Contact:Shelley B. ThunenChief
Financial Officersthunen@rxsight.com
Investor Relations Contact:ir@rxsight.com
Grafico Azioni RxSight (NASDAQ:RXST)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni RxSight (NASDAQ:RXST)
Storico
Da Giu 2023 a Giu 2024